AlphaGrep UK’s Genpact G Stock Holding History

AlphaGrep UK’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,295	Closed	-$495K	–	811
2026 Q1	$495K	Buy	+13,295	New	+$548K	0.14%	250

Other funds holding G

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $377M AUM 37.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AlphaGrep UK's G Position: Q2 2026 in Review

AlphaGrep UK sold out of Genpact (G) in Q2 2026, closing a stake of 13,295 shares — an estimated $495K sold.

AlphaGrep UK first reported a position in G in Q1 2026 and held it in 1 quarter. The position peaked at $495K in Q1 2026. 444 funds tracked by Wall St. Rank hold G as of Q2 2026.

AlphaGrep UK reported no remaining Genpact position as of Q2 2026 after selling out during the quarter.
AlphaGrep UK sold 13,295 Genpact shares in Q2 2026, an estimated $495K.
AlphaGrep UK first reported a position in Genpact in Q1 2026 and held it in 1 quarter.
AlphaGrep UK's Genpact position peaked at $495K in Q1 2026.
444 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.